EN
HI
Summary
As of 14 Oct, 2026, Senores Pharmaceuticals stock price is ₹1321. During the trading session, the stock has moved between an intraday low of ₹1286.60 and an intraday high of ₹1332.00. Over the last 52 weeks, Senores Pharmaceuticals has traded between ₹705.10 and ₹1599.00.
The stock has recorded a trading volume of 1,68,254 shares,. Its Average Traded Price (ATP) is ₹1305.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 14 @ ₹1321.00.
Senores Pharmaceuticals has an upper circuit limit of ₹1582.40 and a lower circuit limit of ₹1055.00. The total value traded stands at ₹21.96 CR, and the delivery percentage for the day is 46.46%.
The stock is currently traded with a market lot size of 1. Senores Pharmaceuticals also offers a dividend yield of 0%.
Senores Pharmaceuticals Share Price Chart
Senores Pharmaceuticals Share Key Metrics
Volume
1.68 L
Market Cap
6083.68 CR
LTQ@LTP
14@1321.00
ATP
1305.16
Var Margin
20.12 %
Circuit Range
1055-1582.4
Delivery %
46.46 %
Value
21.96 CR
ASM/GSM
No
Market Lot
1
Senores Pharmaceuticals Fundamentals
P/E Ratio
48.12
P/B Ratio
6.31
Div. Yield
0
Sector P/E
41.32
Sector P/B
3.47
Sec. Div. Yield
0.53
Senores Pharmaceuticals Resistance and Support
Pivot 1313.2
Resistance
First Resistance
1339.8
Second Resistance
1358.6
Third Resistance
1385.2
Support
First Support
1294.4
Second Support
1267.8
Third Support
1249
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Oct 13 2026 | 1318.69 | 1321 | 0.18% | 1332 | 1286.59 |
| Mon Oct 12 2026 | 1335.09 | 1318.69 | -0.10% | 1349 | 1311 |
| Fri Oct 09 2026 | 1328.8 | 1320 | -0.42% | 1344.4 | 1306.3 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Change in Management
Senores Pharmaceuticals has approved the re-appointment of Swapnil Jatinbhai Shah as Managing Director and Chetan Bipinchandra Shah as Whole Time Director. Both re-appointments are for a term of three years, subject to shareholder approval via postal ballot.
Oct 13 2026 12:23:19
Senores Pharmaceuticals Ltd - 544319 - Board Meeting Outcome for Outcome Of Board Meeting
Senores Pharmaceuticals board has approved the re-appointment of Swapnil Jatinbhai Shah as Managing Director for 3 years effective October 15, 2026. The board also re-appointed Chetan Bipinchandra Shah as Whole Time Director for a 3-year term.
Oct 13 2026 12:18:12
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Morepen Laboratories Ltd.
122.22
0.00 (0.00%)
Sanofi India Ltd.
2956.20
0.00 (0.00%)
Kovai Medical Center & Hospital Ltd.
5929.00
0.00 (0.00%)
Nephrocare Health Services Ltd.
620.95
0.00 (0.00%)
Innova Captab Ltd.
1064.90
0.00 (0.00%)
Orchid Pharma Ltd.
959.95
0.00 (0.00%)
IOL Chemicals And Pharmaceuticals Ltd.
195.11
0.00 (0.00%)
FDC Ltd.
338.45
0.00 (0.00%)
Supriya Lifescience Ltd.
882.25
0.00 (0.00%)
Artemis Medicare Services Ltd.
311.35
0.00 (0.00%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1321 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 48.12. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 6.31. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.32 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 6083.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1599.00 & 705.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SENORES
